Home
About us
Projects
- SpagoPix
- Tumorad
Nanomedicine
- The EPR-effect
- Companion Diagnostics
Publications
Investors
Media
Contact

Home
About us
Projects
- SpagoPix
- Tumorad
Nanomedicine
- The EPR-effect
- Companion Diagnostics
Publications
Investors
Media
Contact

Redeye

Analyst: Klas Palin
klas.palin@redeye.se

Latest research on Spago Nanomedical

Spago Nanomedical develops nanomaterials for improved cancer diagnostics and treatment

News

Improved early detection of breast cancer with MRI compared to mammography in high-risk women
Sep 20 2018
Spago Nanomedical participates in EU NANO2ALL project
Apr 25 2018
SpagoPix featured in international media
Oct 5 2017

Press releases

US patent granted for Tumorad®
Jun 26 2018
Spago Nanomedical select CTC for the first clinical trial with SpagoPix
May 28 2018
SpagoPix shows good safety in regulatory preclinical studies
May 24 2018

Copyright

© 2016 Spago Nanomedical AB.
All rights reserved

Address

Scheelevägen 22
SE-223 63 Lund, Sweden

LinkedIn

Home
About us
Projects
Nanomedicine
Publications
Investors
Media
Contact